CABOTIB 60 – CABOZANTINIB

CABOTIB 60 – CABOZANTINIB is a medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET

CABOTIB 60 mg , 40 mg & 20 mg – CABOZANTINIB indicated to treat advanced cancer in the liver and kidney when other treatments have not worked.

USES OF CABOTIB 60 – CABOZANTINIB

Liver cancer
Kidney cancer
Thyroid cancer